FibroGen

-$0.81 (-4.00%) Today
-$0.31 (-1.60%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell FibroGen and other stocks, options, and ETFs commission-free!

About FGEN

FibroGen, Inc Common Stock, also called FibroGen, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.

CEO
Enrique A. Conterno
Employees
599
Headquarters
San Francisco, California
Founded
1993

FGEN Key Statistics

Market Cap
1.78B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
958.38K
High Today
$20.17
Low Today
$19.26
Open Price
$20.09
Volume
1.08M
52 Week High
$57.21
52 Week Low
$18.12

FGEN News

BenzingaMay 7

Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. – Expanded Class Period

RADNOR, Pa., May 07, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit

FGEN Earnings

-$1.12
-$0.63
-$0.14
$0.35
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.87 per share
Actual
-$0.78 per share
Replay Earnings Call

You May Also Like

VTEB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure